The notion of one-drug binding to one receptor to treat one disease is a dated concept. Using new bioinformatics and cheminfomatics techniques combined with systems biology we are at the beginning of an era when we can better predict the impact of a drug on the complete system. In principle this could lead to more and better drugs. This interview outlines some of these concepts which are to be discussed at the forthcoming Bio-IT Conference in Boston, USA see http://www.bio-itworldexpo.com/Bio-It_Expo_Content.aspx?id=94897
« Hide
